## MNST: Monster Beverage Corporation - XLP: Consumer Defensive

### Executive Summary

No thesis match: MRS_10 0.9% below STRENGTH zone (3.0-6.0%); PEG 1.83 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.1% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($74.62)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 7
- **Sentiment:** Bullish (Bullish: 3, Bearish: 0)

**1. Monster Beverage price target raised to $87 from $81 at Morgan Stanley**
- Source: Yahoo Finance | 20251224T010905 | Bullish | Relevance: 100%
- Morgan Stanley increased its price target for Monster Beverage (MNST) to $87 from $81, maintaining an Overweight rating. This decision is based on strong scanner data, detailed discussions with management, and increased confidence in the company's sustainable growth. Other firms like BofA, Citi, and Stifel have also recently raised their price targets for Monster Beverage.

**2. How Diverging Shorts and AI Optimism Shape Monster Beverageâ€™s (MNST) Evolving Investment Narrative**
- Source: Simply Wall Street | 20251223T170510 | Somewhat-Bullish | Relevance: 100%
- Monster Beverage (MNST) is experiencing heightened investor attention driven by AI and strong sales, but simultaneous high short interest suggests sharply divided opinions on its short-term prospects. Morgan Stanley has raised its price target for MNST, citing robust sales and international expansion, while the article highlights the importance of considering multiple perspectives given varying fair value estimates and ongoing risks like input costs and tariffs. The company projects significant revenue and earnings growth by 2028, aligning its fair value with the current price.

**3. Monster Beverage (MNST): Taking a Fresh Look at Valuation After Rising Institutional Attention and Webinar Buzz**
- Source: Simply Wall Street | 20251222T150846 | Neutral | Relevance: 100%
- Institutional interest and a recent webinar are driving increased attention to Monster Beverage (MNST), sparking debate over its valuation as short interest grows. The stock is currently trading slightly above analysts' fair value estimates, with expectations of continued growth driven by cost controls and supply chain optimization. However, potential risks include a shift towards lower-margin international brands and normalizing energy drink category growth.

**4. Voya Investment Management LLC Reduces Stock Position in Monster Beverage Corporation $MNST**
- Source: MarketBeat | 20251223T134018 | Somewhat-Bullish | Relevance: 100%
- Voya Investment Management LLC reduced its stake in Monster Beverage Corporation (NASDAQ:MNST) by 5.8% in the third quarter, selling 14,971 shares. Despite this, the fund still holds 245,207 shares valued at approximately $16.5 million. Monster Beverage recently exceeded Q3 earnings and revenue estimates, maintaining a "Moderate Buy" consensus analyst rating.

**5. Patton Fund Management Inc. Has $3.03 Million Stake in Monster Beverage Corporation $MNST**
- Source: MarketBeat | 20251223T124025 | Bullish | Relevance: 100%
- Patton Fund Management Inc. significantly increased its stake in Monster Beverage Corporation (NASDAQ:MNST) by 1,099.3%, now owning 45,022 shares valued at approximately $3.03 million. This increase comes as Monster Beverage reported strong Q3 earnings, beating estimates with EPS of $0.56 and revenue of $2.20 billion. Despite recent insider selling, analysts maintain a "Moderate Buy" rating with a consensus target price of $73.95 for the stock.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 8, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-23 | Morgan Stanley | $87 | $81 | +7% |
| 2025-12-17 | Citigroup | $87 | $82 | +6% |
| 2025-12-12 | Stifel | $82 | $78 | +5% |
| 2025-12-03 | Piper Sandler | $85 | $75 | +13% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-23 | Morgan Stanley | main | Overweight |
| 2025-12-17 | Citigroup | main | Buy |
| 2025-12-12 | Stifel | main | Buy |
| 2025-12-03 | Piper Sandler | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 5 ($0.84M) |
| Sells | 4 ($6.05M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 31.1% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 6.9% (+3.2%)
- Blackrock Inc.: 6.1% (+3.7%)
- State Street Corpora: 3.9% (+8.0%)
- Alliancebernstein L.: 3.1% (-13.5%)
- LOOMIS SAYLES & CO L: 2.8% (+1.7%)

### Key Risks

1. Insider selling cluster: $6.1M in recent transactions.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Analyst target momentum: 8 raises (avg +12%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.

### Fundamentals

PEG ratio 1.83 elevated, pricing in significant growth expectations. Forward P/E 34.8x stretched relative to 13% growth. Quality metrics strong (ROE 26%, ROA 17%, margin 22%). Balance sheet: strong liquidity (3.2x), low leverage (D/E 0.24). Analyst sentiment positive (8 raises, avg +12%). Insider selling cluster ($6.1M in 90 days), potential headwind. Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $75.6B |
| Beta | 0.48 |
| 52W Range | $45.70 - $78.31 |
| Short Interest | 2.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.83 |
| Forward P/E | 34.8 |
| Current P/E | 39.4 |
| YoY Growth | 13.2% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 3.0% to 0.9% (-2.1% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 2.1pp (needs >3.0% for momentum thesis). MRS_5 (-0.3%) diverging from MRS_10 - short-term weakness emerging. Full SMA alignment bullish (above 20/50/200 SMAs). OFD pattern: -SLL (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 0.93% (CS: 86) | Neutral |
| RSI_14 | 66.5 | Neutral |
| MACD Histogram | 0.20 | Bullish |
| vs SMA20 | 1.033x | Above |
| vs SMA50 | 1.077x | Above |
| vs SMA200 | 1.204x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $77.42
- **Stop Loss:** $74.62 (3.6% risk)
- **Target:** $80.22 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 214
- **Position Value:** $16,567.88
- **Portfolio %:** 16.57%
- **Risk Dollars:** $600.00
- **Risk Per Trade:** 0.60%
- **Modifiers:** L1 120% | L2 50% | Combined 0.60x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate risk appetite supported by year-end positioning. VIX at cycle lows (13.47) and multiple sectors hitting 52-week highs indicate constructive sentiment, though breadth at 57.9% suggests selectivity remains important. Fed pause expectations and stable macro backdrop support risk assets.*

### Earnings

**Next:** 2026-02-26 (Est: $0.47)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.49 | $0.53 | +9.2% |
| 2025Q2 | $0.48 | $0.50 | +4.1% |
| 2025Q1 | $0.46 | $0.45 | -2.7% |
| 2024Q4 | $0.40 | $0.28 | -29.9% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_10*